Gene · 3783
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators. | Sci Rep | 2023 | 37542141 | PubTator, text mining | PubMed |
| Aberrations in ion channels interacting with lipid metabolism and epithelial-mesenchymal transition in esophageal squamous cell carcinoma. | Front Mol Biosci | 2023 | 37529379 | PubTator, text mining | PubMed |
| Research progress of non-coding RNA in atrial fibrillation. | Front Cardiovasc Med | 2023 | 37522088 | PubTator, text mining | PubMed |
| Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking. | Pharmaceuticals (Basel) | 2023 | 37513925 | PubTator, text mining | PubMed |
| Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines. | Biomedicines | 2023 | 37509712 | PubTator, text mining | PubMed |
| KCa2 and KCa3.1 Channels in the Airways: A New Therapeutic Target. | Biomedicines | 2023 | 37509419 | PubTator, text mining | PubMed |
| Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | 37509279 | PubTator, text mining | PubMed |
| Dual action of Dooku1 on PIEZO1 channel in human red blood cells. | Front Physiol | 2023 | 37492641 | PubTator, text mining | PubMed |
| Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). | Front Pharmacol | 2023 | 37492082 | PubTator, text mining | PubMed |
| Using the integration of human resource management strategies at district level to improve workforce performance: analysis of workplan designs in three African countries. | Hum Resour Health | 2023 | 37488651 | PubTator, text mining | PubMed |
| Blockade of the mineralocorticoid receptor improves markers of human endothelial cell dysfunction and hematological indices in a mouse model of sickle cell disease. | FASEB J | 2023 | 37482902 | PubTator, text mining | PubMed |
| A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma. | Cell Rep Med | 2023 | 37467717 | PubTator, text mining | PubMed |
| Editorial: Glial-targeted therapeutics for CNS disease: getting there from here. | Front Cell Neurosci | 2023 | 37465212 | PubTator, text mining | PubMed |
| Hypokalemia after rituximab administration in nephrotic syndrome: two case reports. | BMC Nephrol | 2023 | 37464309 | PubTator, text mining | PubMed |
| Time to eRAASe chronic inflammation: current advances and future perspectives on renin-angiotensin-aldosterone-system and chronic intestinal inflammation in dogs and humans. | Front Vet Sci | 2023 | 37456955 | PubTator, text mining | PubMed |
| Design of ion channel blocking, toxin-like Kunitz inhibitor peptides from the tapeworm, Echinococcus granulosus, with potential anti-cancer activity. | Sci Rep | 2023 | 37454225 | PubTator, text mining | PubMed |
| TRPM2 Channels: A Potential Therapeutic Target in Melanoma? | Int J Mol Sci | 2023 | 37445615 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the regulatory mechanism underlying the indirubin-mediated amelioration of dextran sulfate sodium-induced colitis in mice. | Pharm Biol | 2023 | 37439220 | PubTator, text mining | PubMed |
| Insights into the mechanisms governing P01 scorpion toxin effect against U87 glioblastoma cells oncogenesis. | Front Pharmacol | 2023 | 37426811 | PubTator, text mining | PubMed |
| Conversion of Unmodified Stem Cells to Pacemaker Cells by Overexpression of Key Developmental Genes. | Cells | 2023 | 37408215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3783/papers?page=13